Dr. David Aldulaimi
Oesophageal, coeliac, colorectal and inflammatory bowel disease and the irritable bowel syndrome.
- British Medical Association
- British Society of Gastroenterology
- Royal College of Physicians
David is a consultant physician and gastroenterologist. He was educated in London. He graduated in Medicine from the University of London, University College and the Middlesex Hospital, in 1992.
He received his general medical training in London and then specialised in general medicine and gastroenterology in the West Midlands. For 2 years he was a research fellow at Walsgrave Hospital and the University of Warwick, studying oesophageal and inflammatory bowel disease, leading to the award of an M.D. His clinical research investigated the long-term outcome for patients diagnosed with oesophageal cancer. His laboratory research investigated the aetiology of inflammatory bowel disease, the molecular basis of inflammation and the effects of immunosuppressant therapy. This research has been presented at local and national conferences and published as original articles in internationally peer-reviewed journals.
His ongoing academic and clinical interests include all aspects of luminal gastroenterology (oesophageal, coeliac, colorectal and inflammatory bowel disease and dietary therapy for the irritable bowel syndrome). He is a member of an international collaboration that has developed a consensus statement for the treatment of early oesophageal cancer and supports national studies investigating oesophageal and inflammatory bowel disease. He has developed a shared care pathway for the management of inflammatory bowel disease and leads local studies investigating coeliac disease and the irritable bowel syndrome.
In 2016 David moved his NHS practice from Worcestershire to Warwickshire.
Oesophageal and gastric cancer
Dis Oesophagus. 1999;12(3):177-80
Barrett's oesophagus: an overview of the molecular biology.
Eur J Gastroenterol Hepatol. 2005 Sep;17(9):943-50
Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival.
Gastroenterology. 2012 Aug;143(2):336-46.
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.
Asian Pac J Cancer Prev. 2012;13(11):5677-9.
Clinical and histological indicators of proximal and distal gastric cancer in eight provinces of Iran.
Coeliac disease and obesity
Saudi Med J. 2010 Aug;31(8):891-4.
Rotavirus and coeliac autoimmunity among adults with non-specific gastrointestinal symptoms.
Arch Iran Med. 2011 Mar;14(2):115-8.
Clinical and histological presentation of Helicobacter pylori and gluten related gastroenteropathy.
Am J Gastroenterol. 2011 Mar;106(3):548-9.
Celiac disease increases the risk of Toxoplasma gondii infection in a large cohort of pregnant women.
Am J Gastroenterol. 2011 Dec;106(12):2202-4.
Nail changes: unusual presentation of celiac disease.
J Gastrointestin Liver Dis. 2012 Mar;21(1):11-5.
Patients with coeliac disease are increasingly overweight or obese on presentation.
Int J Prev Med. 2013 Jun;4(6):700-4.
The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease.
Inflammatory bowel disease
Mol Pathol. 2002 Apr;55(2):83.
New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder?
Aliment Pharmacol Ther. 2005 Jan 15;21(2):121-31.
Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
Outside of work his interests include current affairs, music and bridge.
For further information please visit www.colorectalclinic.uk.com.
Mr Paul Super
F.R.C.S, Laparoscopic Anti-reflux surgery
Mr Paul Super dedicates his practice to upper gastro-intestinal laparoscopic surgery. He is based at Heart of England NHS Trust where there is a very large oesophageal practice.
He performs 3-5 laparoscopic anti-reflux procedures weekly as well as other advanced laparoscopic procedures on the stomach and oesophagus and has been performing this surgery in Birmingham since 1999.
The majority of his anti-reflux surgery is performed as a day-case procedure.
He has a personal experience of over 700 cases of anti-reflux surgery alone.
He is a Fellow of the Royal College Surgeons, and holds memberships of the General Medical Council and Association of Upper GI Surgeons.
He presents widely on laparoscopic anti-reflux surgery at national and International meetings and is highly respected for his contribution to work in this field.